Tumor-associated Tregs suppressed the proliferation of, as well as IFNγ and IL-2 production by, CD8+ T cells specific for the tumor antigen HER2 and thereby counteracted the protective effect of tumor-specific effector T cells (158). This evidence concerns the gene ERBB2 and neoplasm.